Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Nandrolone decanoate/vitamin D3 fixed-dose combination evaluated in multiple doses

June 27, 2014

Coherus' etanercept biosimilar enters phase III trial in rheumatoid arthritis

June 26, 2014

Biosimilar infliximab BOW-015 shows equivalence in phase III trial

June 20, 2014

Flexion reports pharmacokinetic results for FX-006 in knee osteoarthritis

June 20, 2014

BMS-817399 fails to improve rheumatoid arthritis in phase II proof-of-concept study

June 19, 2014

Immunomodulator HMPL-523 enters first-in-human trial

June 19, 2014

Piramal Enterprises patents new proinflammatory cytokine inhibitors

June 19, 2014

NNC-0151-0000 development halted, second-generation compound shows improved profile

June 19, 2014

ABP-501 proves equivalent to adalimumab in healthy volunteers

June 19, 2014

Results from phase I trial of PF-06438179, a biosimilar to infliximab

June 19, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....